Advertisement
Advertisement
Reform

Reform

metformin

Manufacturer:

Lloyd

Distributor:

Pharma Dynamic
Concise Prescribing Info
Contents
Metformin HCl
Indications/Uses
Initial monotherapy or w/ sulphonylurea for diet-failed NIDDM.
Dosage/Direction for Use
NIDDM Initially 500 mg bid or tid or 850 mg once daily or bid. May gradually increase to a max dose of 2-3 g daily.
Administration
Should be taken with food.
Contraindications
Diabetic coma, ketoacidosis, impaired renal function, chronic liver disease. Cardiac failure, recent MI, alcoholism, tissue hypoxia, lactic acidosis. Severe infections, trauma, surgery, dehydration.
Special Precautions
Not to be used in IDDM; patients w/ heart failure, dehydration, acute or chronic alcoholism, or any other condition likely to predispose to lactic acidosis. Associated w/ increased risk of congenital abnormalities & perinatal mortality. Not recommended during breast-feeding.
Adverse Reactions
Anorexia, nausea, & vomiting; impaired absorption of various substances including vit B12. Metallic taste; wt loss. Lactic acidosis.
Drug Interactions
Increased risk of hypoglycemia w/ drugs that lower blood glucose conc. Reduced effect of biguanide therapy w/ drugs that increase blood glucose conc. Increased risk of lactic acidosis & hypoglycaemia w/ alcohol. Concomitant use w/ drugs that may impair renal function.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BA02 - metformin ; Belongs to the class of biguanides. Used in the treatment of diabetes.
Presentation/Packing
Form
Reform FC tab 500 mg
Packing/Price
100's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement